Skip to search formSkip to main contentSkip to account menu

cinnamycin

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Cyclic Peptidesbacteriocin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Nine Post-translational Modifications during the Biosynthesis of Cinnamycin
Lantibiotics are ribosomally synthesized and post-translationally modified antimicrobial peptides that are characterized by the… 
2010
2010
Life‐threatening hemolytic anemia due to an autoanti‐Pr cold agglutinin: evidence that glycophorin A antibodies may induce lipid bilayer exposure and cation permeability independent of agglutination
BACKGROUND: The hemoglobin of a 29‐year‐old man fell below 35 g/L over 5 days, despite 14 units of red blood cells (RBCs), due to… 
Highly Cited
2003
Highly Cited
2003
Cloning and engineering of the cinnamycin biosynthetic gene cluster from Streptomyces cinnamoneus cinnamoneus DSM 40005
Lantibiotics are ribosomally synthesized oligopeptide antibiotics that contain lanthionine bridges derived by the… 
Highly Cited
2003
Highly Cited
2003
Cinnamycin (Ro 09-0198) Promotes Cell Binding and Toxicity by Inducing Transbilayer Lipid Movement*
Cinnamycin is a unique toxin in that its receptor, phosphatidylethanolamine (PE), resides in the inner layer of the plasma… 
Highly Cited
2003
Highly Cited
2003
Specific binding of cinnamycin (Ro 09-0198) to phosphatidylethanolamine. Comparison between micellar and membrane environments.
Cinnamycin (Ro 09-0198) is a tetracyclic peptide antibiotic that binds specifically to phosphatidylethanolamine (PE). Formation… 
Highly Cited
2002
Highly Cited
2002
Specific binding of Ro 09-0198 (cinnamycin) to phosphatidylethanolamine: a thermodynamic analysis.
Ro 09-0198 (cinnamycin) is a tetracyclic peptide antibiotic that is used to monitor the transbilayer movement of… 
Highly Cited
1996
Highly Cited
1996
Structure determination of an immunopotentiator peptide, cinnamycin, complexed with lysophosphatidylethanolamine by 1H-NMR1.
The three-dimensional structure of a complex of cinnamycin, a 19-amino acid residue immunopotentiator peptide, and… 
Highly Cited
1991
Highly Cited
1991
Prepeptide sequence of cinnamycin (Ro 09-0198): the first structural gene of a duramycin-type lantibiotic.
The tetracyclic polypeptide antibiotic cinnamycin (Ro 90-0198) belongs to the duramycin-type lantibiotics and contains the… 
Highly Cited
1991
Highly Cited
1991
Mode of action of the lanthionine-containing peptide antibiotics duramycin, duramycin B and C, and cinnamycin as indirect inhibitors of phospholipase A2.
Highly Cited
1990
Highly Cited
1990
Duramycins B and C, two new lanthionine containing antibiotics as inhibitors of phospholipase A2. Structural revision of duramycin and cinnamycin.
Duramycins B and C, two new lanthionine containing antibiotics, have been isolated from Streptoverticillium strain R2075 and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)